Evidence map›Paper›PMID 29051495›Full record

ArticleNature communications2017

The β20-β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions.

Alon Herschhorn, Christopher Gu, Francesca Moraca, Xiaochu Ma, Mark Farrell, Amos B Smith, Marie Pancera, Peter D Kwong, Arne Schön, Ernesto Freire and 4 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Highly efficient production of HIV-1Journal of virology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Incompletely closed HIV-1Npj viruses · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. mRNA-based HIV-1 vaccines.Clinical microbiology reviews · 2024
    Review
  18. Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Alon HerschhornDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, USA. alon_herschhorn@dfci.harvard.edu.
Christopher GuDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, USA.
Francesca MoracaDepartment of Chemical and Biological Engineering, Drexel University, Philadelphia, Pennsylvania, 19104, USA.
Xiaochu MaDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut, 06536, USA.
Mark FarrellDepartment of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA.
Amos B SmithDepartment of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA.
Marie PanceraVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892, USA.
Peter D KwongVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892, USA.
Arne SchönDepartment of Biology, Johns Hopkins University, Baltimore, Maryland, 21218, USA.
Ernesto FreireDepartment of Biology, Johns Hopkins University, Baltimore, Maryland, 21218, USA.
Cameron AbramsDepartment of Chemical and Biological Engineering, Drexel University, Philadelphia, Pennsylvania, 19104, USA.ORCID http://orcid.org/0000-0002-1240-0816
Scott C BlanchardDepartment of Physiology and Biophysics, Weill Cornell Medical College of Cornell University, New York, New York, 10065, USA.
Walther MothesDepartment of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut, 06536, USA.
Joseph G SodroskiDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, USA. joseph_sodroski@dfci.harvard.edu.
Drexel University · USHarvard University · USJohns Hopkins University · USNational Institutes of Health · USUniversity of Pennsylvania · USYale University · USCornell University · USDana-Farber Cancer Institute · US

Funding

Virus biology scientific research support componentUM1AI100645 · NIAID · DUKE UNIVERSITY · PI MCMICHAEL, ANDREW JAMES · 2012 to 2018
$204.7M
Understanding Envelope Function in HIV-1 Infection: The Design, Synthesis and Validation of Small Molecule HIV-1 Env InhibitorsP01GM056550 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI ABRAMS, CAMERON F · 1997 to 2018
$31.2M
Mechanisms Of Humoral EvasionZIAAI005023 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI ZHOU, TONGQING · 2009 to 2025
$18.6M
HIV-1 ENVELOPE GLYCOPROTEINSR37AI024755 · NIAID · DANA-FARBER CANCER INSTITUTE · PI SODROSKI, JOSEPH G · 1996 to 2015
$11.6M
Conformational Landscape of the HIV-1 Envelope GlycoproteinsR01AI124982 · NIAID · DANA-FARBER CANCER INST · PI SODROSKI, JOSEPH G · 2016 to 2025
$6.7M
Next-generation Fluorescent Probes for Biological ResearchR01GM098859 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI BLANCHARD, SCOTT C · 2012 to 2019
$2.9M
Single molecule imaging of HIV-1 entryR01GM116654 · NIGMS · YALE UNIVERSITY · PI MOTHES, WALTHER H · 2015 to 2018
$1.6M
HIV-1 Env antagonism by ground state stabilizationK22AI116262 · NIAID · TUFTS UNIVERSITY BOSTON · PI MUNRO, JAMES B · 2015 to 2016
$266k
NIAID NIH HHS R01 AI124982NIAID NIH HHS R37 AI024755NIAID NIH HHS UM1 AI100645NIGMS NIH HHS P01 GM056550NIGMS NIH HHS R01 GM098859NIGMS NIH HHS R01 GM116654
6 · The paper itself

Abstract

The entry of HIV-1 into target cells is mediated by the viral envelope glycoproteins (Env). Binding to the CD4 receptor triggers a cascade of conformational changes in distant domains that move Env from a functionally "closed" State 1 to more "open" conformations, but the molecular mechanisms underlying allosteric regulation of these transitions are still elusive. Here, we develop chemical probes that block CD4-induced conformational changes in Env and use them to identify a potential control switch for Env structural rearrangements. We identify the gp120 β20-β21 element as a major regulator of Env transitions. Several amino acid changes in the β20-β21 base lead to open Env conformations, recapitulating the structural changes induced by CD4 binding. These HIV-1 mutants require less CD4 to infect cells and are relatively resistant to State 1-preferring broadly neutralizing antibodies. These data provide insights into the molecular mechanism and vulnerability of HIV-1 entry.

Indexed as

CD4 AntigensHEK293 CellsHIV-1HIV Envelope Protein gp120HumansMolecular ProbesProtein BindingProtein ConformationProtein Conformation, beta-StrandCD4 Antigensgp120 protein, Human immunodeficiency virus 1HIV Envelope Protein gp120Molecular Probes

Identifiers

PMID29051495
PMCPMC5648922
OpenAlexW2761820181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.